Close Menu
Home » lymphoma

lymphoma

Feb 21, 2013

Dx Focus: Diagnovus Engauge-Cancer-DLBCL; Epigenomics Epi ProColon

Premium

Diagnovus this week launched Engauge-Cancer-DLBCL, a gene expression assay designed to aid physicians with risk stratification and treatment of patients with diffuse large B-cell lymphoma.

Jan 10, 2013

Epizyme Taps Roche to Develop Cobas 4800 CDx for Epizyme/Eisai Lymphoma Drug Candidate

Premium

Epizyme this week announced a collaboration with Eisai and Roche to develop an in vitro, PCR-based companion diagnostic test to help treat genetically defined lymphomas.

Oct 03, 2012

Epizyme Publishes Data Suggesting Compound Activity against Lymphoma with EZH2 Mutations

Premium

Researchers from Epizyme and elsewhere have reported that the company's investigational compound EPZ5687 targets and destroys lymphoma cells harboring mutations in EZH2, a type of histone-modifying enzyme.

Sep 26, 2012

NCI Funds PrimeraDx for Lymphoma Assay

NEW YORK (GenomeWeb News) – PrimeraDx has landed a grant from the National Cancer Institute to develop a gene expression profiling assay that can rapidly detect diffuse large B-Cell lymphoma (DLBCL) subgroups, making it easier to diagnose the disease, select treatment options, and predict the lik

Sep 24, 2012

Mayo, Iowa Land $11.5M for Lymphoma Center

NEW YORK (GenomeWeb News) – Researchers at Mayo Clinic and the University of Iowa have received an $11.5 million grant from the National Cancer Institute to fund translational and clinical projects focused on lymphoma, including genomics-based research.

Aug 15, 2012

Sequenta Tests LymphoSight Assay for Monitoring Residual Disease in Two Clinical Trials

Premium

Sequenta's sequencing assay to measure residual disease is now being tested in two clinical trials for mantle cell lymphoma.

Aug 13, 2012

Researchers ID Pathways Contributing to Burkitt Lymphoma

NEW YORK (GenomeWeb News) – An international team led by investigators at the National Institutes of Health has identified new pathogenic pathways in a form of non-Hodgkin's lymphoma called Burk

Aug 07, 2012

Cancer Genetics to Launch Two New Oncology-Focused CGH Array Tests by Year End

Premium

CHICAGO — Cancer Genetics will later this year expand its menu of array-based tests to include assays for informing treatment of patients with diffuse large B-cell lymphoma and renal cell carcinoma.

Jul 02, 2012

NCI Seeks Genomic, Proteomic Markers for Hematopoietic Malignancies

NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund researchers seeking to develop and validate biomarkers that can be used to detect and predict progression of hematopoietic malignancies, such as Hodgkin and non-Hodgkin lymphoma, leukemia, multiple myeloma, and others.

May 09, 2012

MDx/CDx Focus: AssureRx Launches ADHD PGx Test; Adcetris Phase III Study in CD-30 Lymphoma; CardioDx

Premium

AssureRx Launches GeneSightRx ADHD
AssureRx Health this week launched a pharmacogenetic test, called GeneSightRx ADHD, for characterizing patients' response to a variety of attention deficit hyperactivity disorder drugs.

Pages

The Scan

For Scientific Talent

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

Agency Pick Worries Brazilian Researchers

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

Speedy Work

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

PLOS Papers Include Greenlander BMI GWAS, Metabolic MicroRNA Marker Search, More

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more. 

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.